Commonwealth Equity Services »

Fate Therapeutics shares owned by Commonwealth Equity Services

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Commonwealth Equity Services from 13F filings

Historical chart of Commonwealth Equity Services investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Commonwealth Equity Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Commonwealth Equity Services

Quarter filed Position value Share count Share price at filing
2025-12-31 $26k 27k 0.98

More positions owned by Commonwealth Equity Services

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Total Stk Mkt (VTI)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Growth Etf Shs Creation Uni (CGGR)

View all positions for Commonwealth Equity Services

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Group
Wilshire Associates
Johnson & Johnson
Acadian Asset Management
Geode Capital Management
Renaissance Technologies
State Street Corporation
Vestal Point Capital
Dimensional Fund Advisors
Point72 Asset Management
Goldman Sachs Group
Tang Capital Management
AQR Capital Management

View all funds holding Fate Therapeutics